The CEM-NET initiative: molecular biology and epidemiology in alliance--tracking antibiotic-resistant staphylococci and pneumococci in hospitals and in the community.

Herminia de Lencastre, Alexander Tomasz

Abstract readReview

In one paragraph

Review in International journal of medical microbiology : IJMM, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Contamination of public buses with MRSA in Lisbon, Portugal: a possible transmission route of major MRSA clones within the community.PloS one · 2013
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Herminia de LencastreLaboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal.

Alexander Tomasz

Funding

S.AUREUS CELL WALLS AND DRUG RESISTANCE IN MRSA AND VRSAR01AI045738 · NIAID · ROCKEFELLER UNIVERSITY · PI TOMASZ, ALEXANDER · 2000 to 2014

$8.5M

NIAID NIH HHS 2 RO1 AI457838-11NIAID NIH HHS R01 AI045738

6 · The paper itself

Abstract

In this brief report, we provide a portrait of the CEM-NET initiative and review studies that highlight contributions of this molecular epidemiological network to the understanding of the molecular mechanisms of drug resistance in Staphylococcus aureus and Streptococcus pneumoniae clones as well as their routes and modes of geographic expansion.

Indexed as

Bacterial Typing TechniquesDrug Resistance, BacterialAnimalsAnti-Bacterial AgentsCommunity-Acquired InfectionsCross InfectionHospitalsHumansMolecular EpidemiologyPneumococcal InfectionsStaphylococcal InfectionsStaphylococcus aureusStreptococcus pneumoniaeAnti-Bacterial Agents

Identifiers

PMID22000742

DOI10.1016/j.ijmm.2011.09.010

PMCPMC3212844

What OpenQuestion holds

Textmetadata

LicenceTDM

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.